DEVIL-DOG® Dungarees Launches Women's Denim Collection on March 15
Iconic heritage brand expands into women's with high-rise straight leg denim
Founded in 1948 by U.S. Army veteran
The new women's high-rise straight leg jean stays true to DEVIL-DOG®'s roots, combining authentic vintage inspiration with modern fit and comfort. Designed to be worn every day, the silhouette offers a structured yet easy feel, with thoughtful details and premium denim fabrics. The initial launch includes three versatile denim washes, along with a bold five-pocket camo option that reflects the brand's military heritage while offering a fresh, contemporary edge.
"This launch has been a long time coming for our brand," said
The women's denim launch represents the first step in DEVIL-DOG®'s expansion into women's apparel, with additional styles and categories planned for future seasons.
For more information about DEVIL-DOG® Dungarees and the launch of the women's denim collection, please visit devil-dog.com and follow @DEVILDOGJeans on Instagram and Facebook.
About DEVIL-DOG® Dungarees
DEVIL-DOG® Dungarees was first established in 1948, relaunching to the market in 2019 as a heritage-driven lifestyle brand creating vintage-inspired, high-quality apparel at a great value. Originally known for its great-fitting and durable denim jeans, DEVIL-DOG® has expanded into a full lifestyle collection, now including categories such as casual bottoms and shorts, knit tops, graphic tees, denim shirts and jackets, caps, leather accessories, and women's denim.
Media Contact: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/devil-dog-dungarees-launches-womens-denim-collection-on-march-15-302704427.html
SOURCE DEVIL-DOG Dungarees
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GORGIE INTRODUCES BERRY BURST, BRINGING BOLD BERRY FLAVOR AND IT-GIRL STYLE TO MODERN ENERGY
- Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso’s HARMONi-2 Study
- Ivonescimab Versus Pembrolizumab in First-Line PD-L1-Positive NSCLC: Positive Overall Survival Results from HARMONi-2 Presented at WCLC 2026
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share